Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Income from Non-Controlling Interests: 2021-2023

Historic Income from Non-Controlling Interests for ProQR Therapeutics N.V (PRQR) over the last 3 years, with Sep 2023 value amounting to $315,691.

  • ProQR Therapeutics N.V's Income from Non-Controlling Interests rose 2136.43% to $315,691 in Q3 2023 from the same period last year, while for Sep 2023 it was $25,060, marking a year-over-year increase of 105.52%. This contributed to the annual value of $415,380 for FY2023, which is 85.06% up from last year.
  • As of Q3 2023, ProQR Therapeutics N.V's Income from Non-Controlling Interests stood at $315,691, which was up 1,711.94% from $17,423 recorded in Q2 2023.
  • In the past 5 years, ProQR Therapeutics N.V's Income from Non-Controlling Interests registered a high of $315,691 during Q3 2023, and its lowest value of -$690,959 during Q4 2021.
  • Moreover, its 3-year median value for Income from Non-Controlling Interests was -$8,430 (2021), whereas its average is -$43,350.
  • Per our database at Business Quant, ProQR Therapeutics N.V's Income from Non-Controlling Interests spiked by 2,846.79% in 2022 and then tumbled by 92.48% in 2023.
  • Over the past 3 years, ProQR Therapeutics N.V's Income from Non-Controlling Interests (Quarterly) stood at -$690,959 in 2021, then spiked by 43.30% to -$391,775 in 2022, then spiked by 2,136.43% to $315,691 in 2023.
  • Its Income from Non-Controlling Interests was $315,691 in Q3 2023, compared to $17,423 in Q2 2023 and $83,721 in Q1 2023.